Maoru Li
Overview
Explore the profile of Maoru Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma J, Pu R, Zhou Q, Li M, Shang J
Acta Biochim Biophys Sin (Shanghai)
. 2024 Jan;
56(2):327-330.
PMID: 38229545
No abstract available.
2.
Ma J, Li M, Yang T, Deng Y, Ding Y, Guo T, et al.
Int J Mol Sci
. 2023 May;
24(10).
PMID: 37240141
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease with a global prevalence of 25%. However, the medicines approved by the FDA or EMA are still not commercially available...
3.
Cheng L, Wang H, Ma K, Deng Y, Li M, Ma J
Front Pharmacol
. 2023 Apr;
14:1092693.
PMID: 37033659
Rhizoma Gastrodia (Orchidaceae; Blume), the rhizome of Blume (GE), is traditionally used as both a medicinal and functional food, with proven efficacy in treating mental disorders. In traditional processing, GE...
4.
Li M, Xie G, Ding Y, Ma J, Liu Q, Wang Y, et al.
Foods
. 2023 Feb;
12(4).
PMID: 36832980
Boiss. et Huet (CG) and L. (CI) are widely used as the main raw material of functional food with hepatoprotective and hypoglycemic effects. Due to the lack of comparison on...
5.
Ma J, Deng Y, Yang T, Li M, Shang J
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36675107
Non-alcoholic fatty liver disease (NAFLD), defined in recent years as metabolic-associated fatty liver disease (MAFLD), is one of the most common liver diseases in the world, with no drugs on...
6.
Han J, Dong J, Zhang R, Zhang X, Chen M, Fan X, et al.
Mediators Inflamm
. 2021 Sep;
2021:9951946.
PMID: 34475805
Objectives: . (DH) is a Chinese herbal medicine, which is often used to make tea to improve immunity in China. Rumor has it that DH has a protective effect against...
7.
Deng Y, Ma J, Weng X, Wang Y, Li M, Yang T, et al.
Life (Basel)
. 2021 Jun;
11(5).
PMID: 34069176
NAFLD (non-alcoholic fatty liver disease) is one of the most prominent liver diseases in the world. As a metabolic-related disease, the development of NAFLD is closely associated with various degrees...
8.
He Q, Li M, Wang X, Xia Z, Du Y, Li Y, et al.
BMC Chem
. 2019 Aug;
13(1):76.
PMID: 31384823
5-Hydroxytryptamine (also known as 5-HT, serotonin) is one of the monoamine neurotransmitters which is distributed widely in plasma and brain of mammals and plays important roles in physiological manipulations. In...
9.
Ma J, Yin H, Li M, Deng Y, Ahmad O, Qin G, et al.
Int J Biol Sci
. 2019 Jun;
15(5):973-983.
PMID: 31182918
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease around the world. However, there is still no drug for NAFLD in the market, the study of potential...
10.
Ahmad O, Wang B, Ma K, Deng Y, Li M, Yang L, et al.
Int J Mol Sci
. 2019 Apr;
20(8).
PMID: 31018538
Non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) is the most common chronic liver disease in the world. However, there are still no drugs for NAFLD/NASH in the market....